Last updated on September 2017

Study title: A randomized, double blind, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib


Brief description of study

Study title: A randomized, double blind, multicenter phase III study of regorafenib in patients with hepatocellular carcinoma (HCC) after sorafenib

Detailed Study Description

This clinical study evaluates the efficacy and safety of regorafenib in patients with advanced liver cancer who have progressed on sorafenib treatment. Approximately 560 patients who meet the entry criteria will be randomly assigned in a 2:1 ratio to regorafenib or placebo (1/3 chance to receive placebo). Primary endpoint of the study is overall survival.

For Study Locations, Click Here

Clinical Study Identifier: TX153133

Find a site near you

Start Over

Research Center

Located in: Additional Locations, XX Argentina
  Connect »

Research Center

Located in: Additional Locations, XX Australia
  Connect »

Research Center

Located in: Additional Locations, XX Austria
  Connect »

Research Center

Located in: Additional Locations, XX Belgium
  Connect »

Research Center

Located in: Additional Locations, XX Brazil
  Connect »

Research Center

Located in: Additional Locations, XX China
  Connect »

Research Center

Located in: Additional Locations, XX Czechia
  Connect »

Research Center

Located in: Additional Locations, XX France
  Connect »

Research Center

Located in: Additional Locations, XX Germany
  Connect »

Research Center

Located in: Additional Locations, XX Hungary
  Connect »

Research Center

Located in: Additional Locations, XX Italy
  Connect »

Research Center

Located in: Additional Locations, XX Japan
  Connect »

Research Center

Located in: Additional Locations, XX Russian Federation
  Connect »

Research Center

Located in: Additional Locations, XX Spain
  Connect »

Research Center

Located in: Additional Locations, XX United Kingdom
  Connect »

Research Center

Located in: Additional Locations, CA USA
  Connect »

Research Center

Located in: Additional Locations, FL USA
  Connect »

Research Center

Located in: Additional Locations, IL USA
  Connect »

Research Center

Located in: Additional Locations, KY USA
  Connect »

Research Center

Located in: Additional Locations, MA USA
  Connect »

Research Center

Located in: Additional Locations, MO USA
  Connect »

Research Center

Located in: Additional Locations, NY USA
  Connect »

Research Center

Located in: Additional Locations, PA USA
  Connect »

Research Center

Located in: Additional Locations, TX USA
  Connect »

Research Center

Located in: Additional Locations, VA USA
  Connect »

Research Center

Located in: Additional Locations, WA USA
  Connect »

Research Center

Located In: Additional Locations, XX Singapore
  Connect »

Research Center

Located In: Additional Locations, XX Taiwan
  Connect »

Research Center

Located In: Additional Locations, DC USA
  Connect »

Research Center

Located In: Additional Locations, MI USA
  Connect »

Research Center

Located In: Additional Locations, MN USA
  Connect »

Research Center

Located in: Additional Locations, XX Netherlands
  Connect »

Research Center

Located in: Additional Locations, OR USA
  Connect »

Research Center

Located In: Additional Locations, CO USA
  Connect »

Research Center

Located In: Additional Locations, XX Switzerland
  Connect »

Research Center

Located in: Additional Locations, XX Korea
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.